Survival Benefit for Early Initiation of Hormone Ablation Therapy in Patients who Fail Definitive XRT for Prostate Cancer (ACP)

Ryan Smith, MD
University of Pennsylvania Cancer Center
Ultima Vez Modificado: 4 de noviembre del 2001

Translation for this article does not exist